Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-007353
Filing Date
2024-10-16
Accepted
2024-10-16 16:23:23
Documents
1
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5437
  Complete submission text file 0001562180-24-007353.txt   6834
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address
Carruthers R Michael (Reporting) CIK: 0001644467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 241374898

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)